Prognostic and Predictive Value of KRAS Mutation in NSCLC

被引：1
|
作者：
Yamamoto, Satomi [1 ]
Washington, Laurie [1 ]
Komiya, Takefumi [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Med Oncol, Fairway, KS 66205 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2016.04.035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E128 / +
页数：2
相关论文
共 50 条
  • [31] KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
    Lohinai, Zoltan
    Klikovits, Thomas
    Moldvay, Judit
    Ostoros, Gyula
    Raso, Erzsebet
    Timar, Jozsef
    Fabian, Katalin
    Kovalszky, Ilona
    Kenessey, Istvan
    Aigner, Clemens
    Renyi-Vamos, Ferenc
    Klepetko, Walter
    Dome, Balazs
    Hegedus, Balazs
    SCIENTIFIC REPORTS, 2017, 7
  • [32] KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
    Zoltan Lohinai
    Thomas Klikovits
    Judit Moldvay
    Gyula Ostoros
    Erzsebet Raso
    Jozsef Timar
    Katalin Fabian
    Ilona Kovalszky
    István Kenessey
    Clemens Aigner
    Ferenc Renyi-Vamos
    Walter Klepetko
    Balazs Dome
    Balazs Hegedus
    Scientific Reports, 7
  • [33] The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy
    Svaton, Martin
    Fiala, Ondrej
    Pesek, Milos
    Bortlicek, Zbynek
    Minarik, Marek
    Benesova, Lucie
    Topolcan, Ondrej
    ANTICANCER RESEARCH, 2016, 36 (03) : 1077 - 1082
  • [34] Prognostic Characteristics and Immunotherapy Response of Non-Squamous NSCLC Patients with KRAS Mutation in East Asian Populations
    Wu, S.
    Liao, W.
    Su, K.
    Yu, S.
    Yu, C.
    Yang, J. C.
    Shih, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S444 - S444
  • [35] Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
    Sun, Jong-Mu
    Hwang, Deok Won
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    PLOS ONE, 2013, 8 (05):
  • [36] PROGNOSTIC AND PREDICTIVE VALUE OF KRAS MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hwang, Deok Won
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1075 - S1075
  • [37] Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
    Lavacchi, Daniele
    Fancelli, Sara
    Roviello, Giandomenico
    Castiglione, Francesca
    Caliman, Enrico
    Rossi, Gemma
    Venturini, Jacopo
    Pellegrini, Elisa
    Brugia, Marco
    Vannini, Agnese
    Bartoli, Caterina
    Cianchi, Fabio
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Low Frequency of KRAS Mutation in Pancreatic Ductal Adenocarcinomas in Korean Patients and Its Prognostic Value
    Kwon, Mi Jung
    Jeon, Jang Yong
    Park, Hye-Rim
    Nam, Eun Sook
    Cho, Seong Jin
    Shin, Hyung Sik
    Kwon, Ji Hyun
    Kim, Joo Seop
    Han, Boram
    Kim, Dong Hoon
    Choi, Yoon-La
    PANCREAS, 2015, 44 (03) : 484 - 492
  • [39] The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
    Arslan, Esra
    Aksoy, Tamer
    Gursu, Riza Umar
    Dursun, Nevra
    Cakar, Ekrem
    Cermik, Tevfik Fikret
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2020, 29 (01) : 17 - 24
  • [40] KRAS mutation as a mechanism of resistance to Alectinib in ALK rearranged NSCLC
    Batra, Ullas
    Nathany, Shrinidhi
    Sharma, Mansi
    Jain, Parveen
    Bansal, Abhishek
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 3
12345